Carbapenem-resistant OXA-23-producing Acinetobacter baumannii isolates causing ventilator-associated pneumonia

American Journal of Infection Control
Marcelo CarneiroAfonso L Barth

Abstract

No abstract listed.

Citations

Mar 14, 2016·Diagnostic Microbiology and Infectious Disease·Juliana Provasi CardosoAna C Gales
May 15, 2012·Burns : Journal of the International Society for Burn Injuries·Parisa AsadollahiMohammad Emaneini
Aug 28, 2014·Critical Reviews in Microbiology·Jaime LabarcaManuel Guzman-Blanco
Nov 17, 2012·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Laís Lisboa CorrêaClaudia Rezende Vieira de Mendonça-Souza
Jul 25, 2013·Expert Review of Anti-infective Therapy·Juan J MayaMaria Virginia Villegas

Related Concepts

Beta-lactamase OXA-23
Acinetobacter Infections
Antibiotics
Beta-Lactamase
Intensive Care Unit
Carbapenems
Surgical Intensive Care
Antibiotic Resistance, Bacterial
Acinetobacter baumannii
Pneumonia, Ventilator-Associated

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

© 2021 Meta ULC. All rights reserved